Metformin-mediated immunometabolic rewiring attenuates type I interferon-driven dendritic cell inflammation in STAT1 gain-of-function
Gain-of-function (GOF) mutations in STAT1 are associated with immune dysregulation, impaired antifungal immunity and features of chronic type I interferon pathway activation. Here, we investigated whether metformin, a widely used metabolic modulator, can attenuate inflammatory dendritic cell activation in STAT1 GOF....